The U.S. Department of Health and Human Services (HHS) recently issued a rule specifying requirements for registering and reporting summary results information to ClinicalTrials.gov. The new rule expands the legal requirements for submitting information about FDA-regulated drug, biological and device products to ClinicalTrials.gov, and will help make information about clinical trials more accessible to the public.
The NIH issued a complementary policy for registering and submitting information on NIH-funded clinical trials to ClinicalTrials.gov. This policy will likewise help make knowledge from clinical trials more widely available.
Read the news release here.